Literature DB >> 8481900

Amplification of cyclin genes in colorectal carcinomas.

F S Leach1, S J Elledge, C J Sherr, J K Willson, S Markowitz, K W Kinzler, B Vogelstein.   

Abstract

The genetic status of cyclin genes was examined in a panel of 47 colorectal carcinoma cell lines. Cyclin D2 was found to be amplified in one tumor and cyclin E in another. In each of the two cases, the amplified cyclin gene was overexpressed at the protein or mRNA level. Cyclin D1, previously shown to be amplified in breast and other tumors, was not amplified in these cancers. These data suggest that a variety of cyclin genes can play a role in human tumorigenesis and that cyclins D2 and E are particularly important in a subset of colorectal neoplasms.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8481900

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

1.  Cyclin E and chromosome instability in colorectal cancer cell lines.

Authors:  C Simone; N Resta; L Bagella; A Giordano; G Guanti
Journal:  Mol Pathol       Date:  2002-06

2.  Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression.

Authors:  S Mai; J Hanley-Hyde; G J Rainey; T I Kuschak; J T Paul; T D Littlewood; H Mischak; L M Stevens; D W Henderson; J F Mushinski
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

Review 3.  The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer.

Authors:  Katrien Vermeulen; Dirk R Van Bockstaele; Zwi N Berneman
Journal:  Cell Prolif       Date:  2003-06       Impact factor: 6.831

Review 4.  Progress against cancer.

Authors:  S Broder; J E Karp
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

Review 5.  Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies.

Authors:  Joseph A Caruso; Mylinh T Duong; Jason P W Carey; Kelly K Hunt; Khandan Keyomarsi
Journal:  Cancer Res       Date:  2018-09-07       Impact factor: 12.701

6.  Activation of cyclin E-dependent kinase activity in colorectal cancer.

Authors:  W R Cam; T Masaki; T Y Shiratori; N Kato; M Okamoto; Y Yamaji; K Igarashi; T Sano; M Omata
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

7.  p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy.

Authors:  Peggy L Porter; William E Barlow; I-Tien Yeh; Ming Gang Lin; Xiaopu P Yuan; Elizabeth Donato; George W Sledge; Charles L Shapiro; James N Ingle; Charles M Haskell; Kathy S Albain; James M Roberts; Robert B Livingston; Daniel F Hayes
Journal:  J Natl Cancer Inst       Date:  2006-12-06       Impact factor: 13.506

Review 8.  Cyclin D1 and human neoplasia.

Authors:  R Donnellan; R Chetty
Journal:  Mol Pathol       Date:  1998-02

Review 9.  Apoptosis, cancer and the p53 tumour suppressor gene.

Authors:  J M Lee; A Bernstein
Journal:  Cancer Metastasis Rev       Date:  1995-06       Impact factor: 9.264

10.  Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer.

Authors:  I E Schauer; S Siriwardana; T A Langan; R A Sclafani
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.